Itai Kela, PhD, MBA

Critic
DISC Type : C

Director Global External Innovation Outreach at Novo Nordisk

Copenhagen, Capital Region of Denmark, Denmark

Overview

Itai Kela is a scientist and strategist leading external innovation outreach at Novo Nordisk, focusing on cardiometabolic diseases, oncology, and immunology. With postdoctoral training from Stanford and a PhD from Weizmann Institute, he specializes in building strategic partnerships to translate early science into transformative therapies. Colleagues note his exceptional ability to identify potential.


He co-founded a personalized medicine technology company for immunotherapy with a key scientific founder of Kite Pharma.

Personality Overview

Critic

Negotiator

Information Seeker

They are quite likely to negotiate on pricing or other key terms.  They don’t appreciate bells and whistles unless backed by data. They prefer to analyze logically and value objective facts over emotions.

Topics They Care About

Drug Discovery Partnerships
His role at Novo Nordisk is centered on building strategic partnerships with academia and startups to translate early science into new therapies.
AI in Drug Discovery
He has a stated interest in attending events focused on AI-driven drug discovery and technologies that can accelerate drug development.
Biotech Ecosystems
Actively engages with the biotech community by participating in events like BaseLaunch and Tech BBQ to connect with innovators and share insights.

Media Appearances

How Novo Nordisk partners with academia, biotech .... Featured in BaseLaunch

See Now

Work History

10-2023
Director Global External Innovation Outreach at Novo Nordisk
10-2021 - 10-2023
Director, Global External Innovation & Scientific Licensing at Ferring Pharmaceuticals
10-2017 - 10-2021
Head of Healthtech sector at IIA
2-2016 - 10-2017
Director of Business Development - Healthcare at NRGene Ltd.
1-2014 - 6-2017
CEO at CGA- Personalized Medicine Technology

Education

2008 - 2010
Post Doctorate from Stanford University
2002 - 2008
Doctor of Philosophy (Ph.D.) from Weizmann Institute of Science

More Information

Social Presence :

Prographics :

Exp : 15 Location : Copenhagen, Capital Region of Denmark, Denmark Job Level : Mid-senior Designation : Director Global External Innovation Outreach at Novo Nordisk
URL has been copied!

Insights For Selling To Itai

During A Call Or A Meeting

DO's

  • Don’t forget to mention how you compare to competition on both features and pricing
  • Be ready to answer many clarity-seeking questions and requests for information
  • Keep some extra margin while sharing pricing, they are likely to negotiate later

DONT's

  • Don’t try to give too many examples of other users, they like to make their own decisions
  • Don't give superficial answers, they are easily rattled by them
  • Don’t try too hard to build a relationship with them

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Itai is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Itai

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Itai move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Itai take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Itai

Personality Compatibility


Other Novo Nordisk Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.